ZA949611B - Protein kinase C inhibitors - Google Patents

Protein kinase C inhibitors

Info

Publication number
ZA949611B
ZA949611B ZA949611A ZA949611A ZA949611B ZA 949611 B ZA949611 B ZA 949611B ZA 949611 A ZA949611 A ZA 949611A ZA 949611 A ZA949611 A ZA 949611A ZA 949611 B ZA949611 B ZA 949611B
Authority
ZA
South Africa
Prior art keywords
inhibitors
protein kinase
kinase
protein
Prior art date
Application number
ZA949611A
Other languages
English (en)
Inventor
William Francis Heath Jr
Michael Robert Jirousek
John Hampton Mcdonald Iii
Christopher John Rito
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA949611B publication Critical patent/ZA949611B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA949611A 1993-12-07 1994-12-02 Protein kinase C inhibitors ZA949611B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16306093A 1993-12-07 1993-12-07

Publications (1)

Publication Number Publication Date
ZA949611B true ZA949611B (en) 1996-06-03

Family

ID=22588314

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949611A ZA949611B (en) 1993-12-07 1994-12-02 Protein kinase C inhibitors

Country Status (4)

Country Link
US (1) US5541347A (ko)
KR (1) KR100340270B1 (ko)
TW (1) TW358803B (ko)
ZA (1) ZA949611B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2217797A (en) * 1996-03-20 1997-10-10 Eli Lilly And Company Synthesis of indolylmaleimides
IL128376A0 (en) * 1996-08-23 2000-01-31 Lilly Co Eli Synthesis of bisindolylmalimides
US5721272A (en) * 1996-11-18 1998-02-24 Eli Lilly And Company Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
US6133452A (en) * 1997-08-22 2000-10-17 Eli Lilly And Company Synthesis of bisindolylmalimides
JP3646651B2 (ja) * 1998-01-30 2005-05-11 ダイソー株式会社 ブタントリオール誘導体の製造法
GB9828640D0 (en) * 1998-12-23 1999-02-17 Smithkline Beecham Plc Novel method and compounds
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
EP0303697B1 (en) * 1987-03-09 1997-10-01 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance k-252
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
DE3914764A1 (de) * 1989-05-05 1990-11-08 Goedecke Ag Maleinimid-derivate und deren verwendung als arzneimittel
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
DE3942296A1 (de) * 1989-12-21 1991-06-27 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
AU5100393A (en) * 1992-09-25 1994-04-26 Schering Corporation Diindolo compounds and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR950018011A (ko) 1995-07-22
US5541347A (en) 1996-07-30
TW358803B (en) 1999-05-21
KR100340270B1 (ko) 2002-12-02

Similar Documents

Publication Publication Date Title
CY2561B1 (en) Protein kinase C inhibitors
EG23871A (en) Protein kinase c inhibitor
AU5324996A (en) Protein kinase c inhibitors
EP0706657A4 (en) INTERACTIONS OF INHIBITION PROTEINS
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU6236594A (en) Adenosine kinase inhibitors
PL330120A1 (en) Farnesilic protein transferase inhibitors
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
HUP9903694A3 (en) Medicines comprising rho kinase inhibitor
EP0630245A4 (en) PROTEIN KINASE C INHIBITOR.
AU7467294A (en) Tyrosine kinase inhibitor
AU6882598A (en) Protein kinase inhibitor
GB9315846D0 (en) Tumour inhibitors
HK1019147A1 (en) Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
AU1783092A (en) Inhibitors of protein kinase c function
GB9314802D0 (en) Modified proteins
ZA949611B (en) Protein kinase C inhibitors
IL122092A0 (en) Protein kinase C inhibitors
SI0657458T1 (en) Protein kinase C inhibitors
GB9321344D0 (en) Protein kinases
GB9311047D0 (en) Protein kinases
GB9316099D0 (en) Protein kinases
GB9313763D0 (en) Protein kinases
GB9304680D0 (en) Protein kinases
ZA949525B (en) Enzyme inhibitors